vs

Side-by-side financial comparison of bioAffinity Technologies, Inc. (BIAF) and Catalyst Bancorp, Inc. (CLST). Click either name above to swap in a different company.

Catalyst Bancorp, Inc. is the larger business by last-quarter revenue ($2.7M vs $1.6M, roughly 1.7× bioAffinity Technologies, Inc.). Catalyst Bancorp, Inc. runs the higher net margin — 17.2% vs -197.0%, a 214.2% gap on every dollar of revenue. On growth, Catalyst Bancorp, Inc. posted the faster year-over-year revenue change (1.4% vs -27.8%). Catalyst Bancorp, Inc. produced more free cash flow last quarter ($3.1M vs $-2.6M). Over the past eight quarters, Catalyst Bancorp, Inc.'s revenue compounded faster (12.6% CAGR vs -18.6%).

bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.

Catalyst Bancorp, Inc. is a U.S.-based financial holding company that operates community banking subsidiaries. It provides a full range of retail and commercial banking products including checking and savings accounts, small business loans, residential mortgages, personal lending, and wealth management services, primarily serving local regional markets across the U.S. with a focus on individual consumers and small business clients.

BIAF vs CLST — Head-to-Head

Bigger by revenue
CLST
CLST
1.7× larger
CLST
$2.7M
$1.6M
BIAF
Growing faster (revenue YoY)
CLST
CLST
+29.3% gap
CLST
1.4%
-27.8%
BIAF
Higher net margin
CLST
CLST
214.2% more per $
CLST
17.2%
-197.0%
BIAF
More free cash flow
CLST
CLST
$5.7M more FCF
CLST
$3.1M
$-2.6M
BIAF
Faster 2-yr revenue CAGR
CLST
CLST
Annualised
CLST
12.6%
-18.6%
BIAF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BIAF
BIAF
CLST
CLST
Revenue
$1.6M
$2.7M
Net Profit
$-3.1M
$456.0K
Gross Margin
Operating Margin
-196.9%
20.8%
Net Margin
-197.0%
17.2%
Revenue YoY
-27.8%
1.4%
Net Profit YoY
-5.7%
-27.2%
EPS (diluted)
$-3.59
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIAF
BIAF
CLST
CLST
Q4 25
$1.6M
$2.7M
Q3 25
$1.4M
$2.8M
Q2 25
$1.3M
$2.8M
Q1 25
$1.9M
$2.9M
Q4 24
$2.2M
$2.5M
Q3 24
$2.4M
$3.2M
Q2 24
$2.4M
$2.8M
Q1 24
$2.4M
$2.1M
Net Profit
BIAF
BIAF
CLST
CLST
Q4 25
$-3.1M
$456.0K
Q3 25
$-5.1M
$489.0K
Q2 25
$-4.1M
$521.0K
Q1 25
$-2.7M
$586.0K
Q4 24
$-3.0M
$626.0K
Q3 24
$-2.0M
$447.0K
Q2 24
$-2.1M
$527.0K
Q1 24
$-2.0M
$-4.7M
Operating Margin
BIAF
BIAF
CLST
CLST
Q4 25
-196.9%
20.8%
Q3 25
-158.6%
21.7%
Q2 25
-198.2%
22.5%
Q1 25
-141.7%
24.7%
Q4 24
-133.5%
31.2%
Q3 24
-84.0%
17.6%
Q2 24
-87.1%
23.0%
Q1 24
-80.8%
-284.6%
Net Margin
BIAF
BIAF
CLST
CLST
Q4 25
-197.0%
17.2%
Q3 25
-349.3%
17.7%
Q2 25
-319.9%
18.5%
Q1 25
-143.5%
20.1%
Q4 24
-134.4%
25.3%
Q3 24
-85.1%
14.2%
Q2 24
-88.0%
18.7%
Q1 24
-81.5%
-224.0%
EPS (diluted)
BIAF
BIAF
CLST
CLST
Q4 25
$-3.59
$0.13
Q3 25
$-4.74
$0.13
Q2 25
$-0.17
$0.14
Q1 25
$-0.16
$0.16
Q4 24
$-17.27
$0.13
Q3 24
$-4.84
$0.11
Q2 24
$-0.19
$0.13
Q1 24
$-0.20
$-1.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIAF
BIAF
CLST
CLST
Cash + ST InvestmentsLiquidity on hand
$6.4M
$25.2M
Total DebtLower is stronger
$14.7M
Stockholders' EquityBook value
$7.3M
$81.7M
Total Assets
$11.0M
$282.9M
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIAF
BIAF
CLST
CLST
Q4 25
$6.4M
$25.2M
Q3 25
$7.7M
$37.3M
Q2 25
$802.8K
$40.1M
Q1 25
$444.7K
$40.3M
Q4 24
$1.1M
$44.3M
Q3 24
$756.6K
$45.8M
Q2 24
$801.3K
$75.5M
Q1 24
$2.5M
$76.0M
Total Debt
BIAF
BIAF
CLST
CLST
Q4 25
$14.7M
Q3 25
$14.7M
Q2 25
Q1 25
Q4 24
$9.6M
Q3 24
$29.5M
Q2 24
$30.3M
Q1 24
$29.4M
Stockholders' Equity
BIAF
BIAF
CLST
CLST
Q4 25
$7.3M
$81.7M
Q3 25
$8.9M
$81.6M
Q2 25
$-2.1M
$80.8M
Q1 25
$1.4M
$80.6M
Q4 24
$2.6M
$80.2M
Q3 24
$3.1M
$81.7M
Q2 24
$3.4M
$81.0M
Q1 24
$5.3M
$81.3M
Total Assets
BIAF
BIAF
CLST
CLST
Q4 25
$11.0M
$282.9M
Q3 25
$11.5M
$283.8M
Q2 25
$4.8M
$273.8M
Q1 25
$5.5M
$271.6M
Q4 24
$6.5M
$276.7M
Q3 24
$6.6M
$280.6M
Q2 24
$6.7M
$295.3M
Q1 24
$8.0M
$282.0M
Debt / Equity
BIAF
BIAF
CLST
CLST
Q4 25
0.18×
Q3 25
0.18×
Q2 25
Q1 25
Q4 24
0.12×
Q3 24
0.36×
Q2 24
0.37×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIAF
BIAF
CLST
CLST
Operating Cash FlowLast quarter
$-2.6M
$3.3M
Free Cash FlowOCF − Capex
$-2.6M
$3.1M
FCF MarginFCF / Revenue
-160.7%
116.8%
Capex IntensityCapex / Revenue
0.0%
7.1%
Cash ConversionOCF / Net Profit
7.21×
TTM Free Cash FlowTrailing 4 quarters
$-9.4M
$5.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIAF
BIAF
CLST
CLST
Q4 25
$-2.6M
$3.3M
Q3 25
$-2.5M
$912.0K
Q2 25
$-2.6M
$1.2M
Q1 25
$-1.6M
$427.0K
Q4 24
$-1.7M
$3.2M
Q3 24
$-1.7M
$896.0K
Q2 24
$-1.5M
$1.4M
Q1 24
$-2.3M
$247.0K
Free Cash Flow
BIAF
BIAF
CLST
CLST
Q4 25
$-2.6M
$3.1M
Q3 25
$-2.5M
$827.0K
Q2 25
$-2.7M
$1.1M
Q1 25
$-1.7M
$361.0K
Q4 24
$-1.7M
$2.7M
Q3 24
$-1.7M
$771.0K
Q2 24
$-1.6M
$1.2M
Q1 24
$-2.4M
$223.0K
FCF Margin
BIAF
BIAF
CLST
CLST
Q4 25
-160.7%
116.8%
Q3 25
-171.8%
29.9%
Q2 25
-209.6%
39.7%
Q1 25
-91.3%
12.4%
Q4 24
-76.0%
110.9%
Q3 24
-73.1%
24.5%
Q2 24
-65.1%
41.5%
Q1 24
-99.2%
10.7%
Capex Intensity
BIAF
BIAF
CLST
CLST
Q4 25
0.0%
7.1%
Q3 25
0.3%
3.1%
Q2 25
1.1%
1.2%
Q1 25
2.7%
2.3%
Q4 24
0.0%
17.4%
Q3 24
0.4%
4.0%
Q2 24
1.2%
8.0%
Q1 24
1.7%
1.1%
Cash Conversion
BIAF
BIAF
CLST
CLST
Q4 25
7.21×
Q3 25
1.87×
Q2 25
2.21×
Q1 25
0.73×
Q4 24
5.07×
Q3 24
2.00×
Q2 24
2.64×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons